Siemens Healthineers

Siemens Healthineers is a leading medtech company with over 125 years of experience. We pioneer breakthroughs in healthcare. For everyone. Everywhere. Sustainably. Our portfolio, spanning in vitro and in vivo diagnostics to image-guided therapy and cancer care, is crucial for clinical decision-making and treatment pathways. The company traces its origins to its first medical X-ray device, created in 1896, one year after X-rays were discovered. Siemens Healthineers was formed when Siemens spun off its medtech business in 2016, and its shares are listed on the Frankfurt Stock Exchange and included in the DAX index. Its product history includes the Vidoson real-time ultrasound system, the Somatom Plus-S spiral CT, the Atellica Solution for clinical chemistry and immunodiagnostics, and the Naeotom Alpha photon-counting CT system, along with Varian radiotherapy systems such as ProBeam and Ethos.

With our strengths in patient twinning, precision therapy, as well as digital, data, and artificial intelligence (AI), we are well positioned to take on the greatest challenges in healthcare. We will continue to build on these strengths to help overcome the world’s most threatening diseases, enable efficient operations, and expand access to care. The diseases the company targets include neurodegenerative and cardiovascular diseases, stroke, and cancer. It invests about €1.5 billion annually in research and development and holds about 24,000 technical intellectual property rights, including more than 15,000 granted patents.

We are a team of more than 71,000 Healthineers in over 70 countries passionately pushing the boundaries of what is possible in healthcare to help improve the lives of people around the world. The company is a member of the UN Global Compact, and its emissions reduction targets are approved by the Science Based Targets initiative.